Company

United InnoMed

United InnoMed develops implantable products and heart failure management solutions.

About

Founded in 2020 and based in Shanghai, China, United InnoMed develops Class III active implantable products for heart failure management. Its pipeline includes long-term implants for chronic heart failure and short-term electrical circulatory support products for hospitalized patients with acute heart failure. Founder and CEO Wang Li is a fellow of the Heart Rhythm Society of America, and the company has acquired over 100 invention patents. In April 2025, it raised venture funding co-led by Lapam Capital and Dalton Venture for research, development and clinical registration.

1Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in